Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of ex vivo expanded human NK cells on antileukemia activity in SCID-beige mice.

Leukemia - 1 May 2006

Guimarães F, Guven H, Donati D, Christensson B, Ljunggren H G, Bejarano M T, Dilber M S

Abstract excerpt

The possibility of using natural killer (NK) cells in treatment of human hematological malignancies has increased in recent years. One factor contributing to this is the introduction of new methods for ex vivo generation of enriched populations of clinical grade NK cells. The objective of the present study was to evaluate the safety and efficacy of human ex vivo expanded clinical grade NK cells against K562...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Transplantation
Share to Cytotoxicity, Immunologic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Graft vs Host Disease

Share to Immunotherapy, Adoptive

Share to Injections, Intraperitoneal

Share to K562 Cells

Share to Leukemia, Experimental

Share to Transplantation, Heterologous

Source

Identifiers

PMID: 16511516
DOI: 10.1038/sj.leu.2404147

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of ex vivo expanded human NK cells on antileukemia activity in SCID-beige mice.PMID 16511516Read ↗

Bringing natural killer cells to the clinic: ex vivo manipulationSemantic proximity Read ↗

Immunophenotypic and functional characterization of ex vivo expanded natural killer cells for clinical use in acute lymphoblastic leukemia patients.Semantic proximity Read ↗

An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells.Semantic proximity Read ↗

Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity.Semantic proximity Read ↗

Studies of ex Vivo Activated and Expanded CD8+ NK-T Cells in Humans and MiceSemantic proximity Read ↗

Improving the Outcome of Leukemia by Natural Killer Cell-Based Immunotherapeutic StrategiesSemantic proximity Read ↗

Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-CD52 monoclonal antibodies.Semantic proximity Read ↗

Directed Differentiation of Mobilized Hematopoietic Stem and Progenitor Cells into Functional NK cells with Enhanced Antitumor Activity.Semantic proximity Read ↗

Differences in Tumor Growth and Differentiation in NSG and Humanized-BLT Mice; Analysis of Human vs. Humanized-BLT-Derived NK Expansion and FunctionsSemantic proximity Read ↗

Isolation and analysis of human natural killer cell subsets.Semantic proximity Read ↗

Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production.Semantic proximity Read ↗

Phenotypic and functional characterisation of locally produced natural killer cells ex vivo expanded with the K562-41BBL-mbIL21 cell line.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.